Skip Navigation

Cardiovascular Research 1997 35(1):6-12; doi:10.1016/S0008-6363(97)00076-X
© 1997 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Swynghedauw, B.
Right arrow Articles by Carré, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Swynghedauw, B.
Right arrow Articles by Carré, F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1997, European Society of Cardiology

Cardiac hypertrophy, arrhythmogenicity and the new myocardial phenotype. II. The cellular adaptational process

Bernard Swynghedauwa,*, Brigitte Chevaliera, Daniéle Charlemagnea, Pascale Mansiera and François Carréb

aU127-INSERM, Hôpital Lariboisière, 41 Bd de la Chapelle, 75475, Paris CEDEX, France
bDépartement de Physiologie, Faculté de Médecine, Rennes, France

* Corresponding author. Tel.: +33 (1) 42858065; fax: +33 (1) 48742315.

Ventricular fibrosis is not the only structural determinant of arrhythmias in left ventricular hypertrophy. In an experimental model of compensatory cardiac hypertrophy (CCH) the degree of cardiac hypertrophy is also independently linked to ventricular arrhythmias. Cardiac hypertrophy reflects the level of adaptation, and matches the adaptational modifications of the myocardial phenotype. We suggest that these modifications have detrimental aspects. The increased action potential (AP) and QT duration and the prolonged calcium transient both favour spontaneous calcium oscillations, and both are potentially arrhythmogenic and linked to phenotypic changes in membrane proteins. To date, only two ionic currents have been studied in detail: Ito is depressed (likely the main determinant in AP duration), and If, the pacemaker current, is induced in the overloaded ventricular myocytes. In rat CCH, the two components of the sarcoplasmic reticulum, namely Ca2+-ATPase and ryanodine receptors, are down-regulated in parallel. Nevertheless, while the inward calcium current is unchanged, the functionally linked duo composed of the Na+/Ca2+ exchanger and (Na+, K+)-ATPase, is less active. Such an imbalance may explain the prolonged calcium transient. The changes in heart rate variability provide information about the state of the autonomic nervous system and has prognostic value even in CCH. Transgenic studies have demonstrated that the myocardial adrenergic and muscarinic receptor content is also a determining factor. During CCH, several phenotypic membrane changes participate in the slowing of contraction velocity and are thus adaptational. They also have a detrimental counterpart and, together with fibrosis, favour arrhythmias.

KEYWORDS Arrhythmias; Heart rate, variability; Cardiac hypertrophy, compensatory; Calcium transients; Na+/Ca2+ exchange; Phenotype


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
M. Peschar, K. Vernooy, W. Y.R Vanagt, R. S Reneman, M. A Vos, and F. W Prinzen
Absence of reverse electrical remodeling during regression of volume overload hypertrophy in canine ventricles
Cardiovasc Res, June 1, 2003; 58(3): 510 - 517.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. K. Arnett, R. B. Devereux, D. Kitzman, A. Oberman, P. Hopkins, L. Atwood, A. Dewan, and D. C. Rao
Linkage of Left Ventricular Contractility to Chromosome 11 in Humans: The HyperGEN Study
Hypertension, October 1, 2001; 38(4): 767 - 772.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y. M. Pinto, S.-J. Pinto-Sietsma, T. Philipp, S. Engler, P. Ko{beta}mehl, B. Hocher, H. Marquardt, S. Sethmann, R. Lauster, H.-J. Merker, et al.
Reduction in Left Ventricular Messenger RNA for Transforming Growth Factor {beta}1 Attenuates Left Ventricular Fibrosis and Improves Survival Without Lowering Blood Pressure in the Hypertensive TGR(mRen2)27 Rat
Hypertension, November 1, 2000; 36(5): 747 - 754.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
R. Wolk
Arrhythmogenic mechanisms in left ventricular hypertrophy
Europace, January 1, 2000; 2(3): 216 - 223.
[Abstract] [PDF]


Home page
Circ. Res.Home page
A. D. Wickenden, P. Lee, R. Sah, Q. Huang, G. I. Fishman, and P. H. Backx
Targeted Expression of a Dominant-Negative Kv4.2 K+ Channel Subunit in the Mouse Heart
Circ. Res., November 26, 1999; 85(11): 1067 - 1076.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. Bursac, M. Papadaki, R. J. Cohen, F. J. Schoen, S. R. Eisenberg, R. Carrier, G. Vunjak-Novakovic, and L. E. Freed
Cardiac muscle tissue engineering: toward an in vitro model for electrophysiological studies
Am J Physiol Heart Circ Physiol, August 1, 1999; 277(2): H433 - H444.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. Soeller and M. B. Cannell
Examination of the Transverse Tubular System in Living Cardiac Rat Myocytes by 2-Photon Microscopy and Digital Image–Processing Techniques
Circ. Res., February 19, 1999; 84(3): 266 - 275.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. Macchi, M. Cavalieri, D. Stilli, E. Musso, S. Baruffi, G. Olivetti, P. R. Ershler, R. L. Lux, and B. Taccardi
High-density epicardial mapping during current injection and ventricular activation in rat hearts
Am J Physiol Heart Circ Physiol, November 1, 1998; 275(5): H1886 - H1897.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. Lee, G. Morley, Q. Huang, A. Fischer, S. Seiler, J. W. Horner, S. Factor, D. Vaidya, J. Jalife, and G. I. Fishman
Conditional lineage ablation to model human diseases
PNAS, September 15, 1998; 95(19): 11371 - 11376.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.